{{Rsnum
|rsid=11163585
|Chromosome=1
|position=82846152
|Orientation=plus
|GMAF=0.1772
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 44.1 | 46.8 | 9.0
| HCB | 91.0 | 8.2 | 0.7
| JPT | 95.4 | 4.6 | 0.0
| YRI | 70.5 | 28.1 | 1.4
| ASW | 63.2 | 26.3 | 10.5
| CHB | 91.0 | 8.2 | 0.7
| CHD | 93.5 | 6.5 | 0.0
| GIH | 35.6 | 49.5 | 14.9
| LWK | 62.6 | 34.6 | 2.8
| MEX | 78.9 | 15.8 | 5.3
| MKK | 45.2 | 46.5 | 8.4
| TSI | 47.1 | 47.1 | 5.9
| HapMapRevision=28
}}{{PMID|20195266|OA=1
}} gwas, among 738 schizophrenics genotyped for 492K SNPs, this SNP attained a p-val of 9 x 10^-7 for high density lipoprotein (HDL) as a result of [[perphenazine]] use

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}